Associations between HLA class I alleles and HIV progression in populations exhibiting
Amerindian and Caucasian genetic admixture remain understudied. Using univariable and …

When the A(H1N1)pdm09 pandemic influenza virus moved into the post-pandemic period,
there was a worldwide predominance of the seasonal influenza A(H3N2) and B viruses. …

Objective: Pretreatment HIV-drug resistance (PDR, HIVDR) to non-nucleoside reverse
transcriptase inhibitors (NNRTIs) is increasing globally. NNRTIs continue to be used as first-line …

Introduction We performed a longitudinal SARS-CoV-2 seroepidemiological study in healthcare
personnel of the two largest tertiary COVID-19 referral hospitals in Mexico City. Methods …

OBJECTIVE: To assess human immunodeficiency virus (HIV) diversity and the prevalence
of transmitted drug resistance (TDR) in Guatemala. METHODS: One hundred forty-five …

HLA-B* 35 has consistently been associated with rapid HIV disease progression, particularly
alleles of the Px group. As B* 35 is the most prevalent HLA-B in Mexico, we investigated …

The nucleoside reverse transcriptase inhibitor abacavir (ABC) is used commonly to treat young
children with HIV infection and is a component of the fixed-dose-combination Triumeq ® . …

Resistance to cisplatin is the main cause of treatment failure in lung adenocarcinoma. Drug-tolerant-persister
(DTP) cells are responsible for intrinsic resistance, since they survive the …

Global population immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
is accumulating through heterogeneous combinations of infection and vaccination. …

Previous studies have demonstrated that effective cytotoxic T lymphocyte (CTL) responses
drive the selection of escape mutations that reduce viral replication capacity (VRC). Escape …